Product image of Levofloxacina Vioser (Levofloxacin) supplied by GNH India

Levofloxacina Vioser

Active Ingredient:
Levofloxacin
Origin:
EU

Levofloxacina Vioser (Levofloxacin)

Levofloxacin, the active ingredient in Levofloxacina Vioser, is a fluoroquinolone antibiotic presented as an intravenous solution for injection use. It treats a range of serious bacterial infections in adult patients, including respiratory, urinary and skin infections.

GNH India supplies Levofloxacina Vioser as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Vioser S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levofloxacina Vioser is indicated for several bacterial infections affecting different organ systems.

  • Community‑acquired pneumonia: effective in eradicating the causative pathogens and improving respiratory symptoms.
  • Complicated urinary tract infection: eliminates uropathogens and resolves systemic signs of infection.
  • Skin and soft tissue infections: clears bacterial involvement and promotes wound healing.
  • Acute bacterial sinusitis: reduces sinus inflammation by targeting the infecting organisms.

How It Works

  • Levofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By blocking these targets, the drug prevents bacterial cell division and leads to bacterial cell death, providing a bactericidal effect against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Side Effects

Levofloxacina Vioser may be associated with a range of adverse reactions, which are categorised by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, occasionally watery.
  • Headache: transient cranial discomfort.
  • Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects

  • Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon.
  • QT interval prolongation: may precipitate ventricular arrhythmias.
  • Severe allergic reaction: anaphylaxis with airway compromise.
  • Clostridioides difficile colitis: severe diarrhea with abdominal pain.
  • Central nervous system effects: seizures or hallucinations in susceptible individuals.

Precautions & Warnings

Levofloxacina Vioser requires careful patient assessment and monitoring to minimise risks.

  • Renal function: dose adjustment may be needed in patients with impaired clearance.
  • Cardiac risk: monitor QT interval in patients with known prolongation or electrolyte disturbances.
  • Tendon health: avoid use in patients with recent tendon injury or those on corticosteroids.
  • Hypersensitivity: discontinue immediately if signs of allergic reaction appear.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Levofloxacina Vioser can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: reduce levofloxacin absorption, decreasing effectiveness.
  • Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

  • Theophylline: levofloxacin can raise serum theophylline levels, risking toxicity.
  • Ciprofloxacin: combined use may add to QT‑prolongation potential.
  • Diabetes medications (insulin, sulfonylureas): may cause unexpected hypoglycaemia.

Frequently Asked Questions

Levofloxacina Vioser is an intravenous fluoroquinolone antibiotic used to treat serious bacterial infections such as community‑acquired pneumonia, complicated urinary tract infections, skin and soft‑tissue infections, and acute bacterial sinusitis in adult patients.

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition stops bacterial cell division and leads to rapid bacterial death, providing a broad‑spectrum bactericidal effect.

The specific dose and infusion rate are determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and other clinical factors. No fixed regimen is provided here.

Safety data in pregnancy and lactation are limited. The product should be used only if the potential therapeutic benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Levofloxacina Vioser (levofloxacin) offers a once‑daily dosing option and a broad Gram‑positive and Gram‑negative spectrum, similar to other fluoroquinolones. Compared with older agents like ciprofloxacin, levofloxacin often provides higher potency against respiratory pathogens and better tissue penetration, but the safety profile and resistance patterns must be considered for each patient.

The product should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required for infusion.

Levofloxacina Vioser is given by intravenous infusion. The infusion rate and duration are set by the prescribing clinician, typically over 30‑60 minutes, and the medication is administered under aseptic conditions in a clinical setting.

Serious adverse events include tendon rupture (especially Achilles), QT‑interval prolongation leading to arrhythmias, severe hypersensitivity reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be educated to report sudden tendon pain, palpitations, or severe skin reactions promptly.

Levofloxacina Vioser is contraindicated in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, and it should be avoided in patients with a history of tendon disorders related to fluoroquinolone therapy. Caution is also advised for patients with significant cardiac arrhythmias or uncontrolled epilepsy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levofloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT